Table 5.

Stepwise multivariable linear regression with QTc interval as dependent variable. To minimize risk of collinearity, these were entered into separate models: β blocker, heart disease, and hypercholesterolemia, as well as anti-CCP positivity and RF positivity. Standardized β and unstandardized (B) coefficients are shown.

VariableβB95% CIp
QTBAZ as dependent variable, stepwise linear regression
Model 1, R2 = 0.220
   Age0.2630.4870.175–0.8000.003
   Female sex0.23611.7193.354–20.0830.006
   CRP0.2780.3000.118–0.4830.001
Model 2, R2 = 0.211
   Age0.2640.4890.169–0.8080.003
   Female sex0.21010.4411.894–18.9870.017
   β blocker−0.177−9.973−19.647 – −0.2980.043
   IL-10, tertiles, per unit increase0.2025.4570.754–10.1600.023
QTFHS as dependent variable, stepwise linear regression
Model 3, R2 = 0.238
   Heart disease0.35120.32110.562–30.080< 0.001
   HCQ0.24811.1973.650–18.7440.004
   IL-10, tertiles, per unit increase0.2234.8301.205–8.4550.009
  • The following variables were entered into the stepwise multivariable regression analysis: models 1 and 2 (age, female sex, CRP, IL-6, TNF-α, IL-1α, IL-1β, IL-10, heart disease, β blocker, and hydroxychloroquine), and Model 3 [age, female sex, TNF-α (tertiles), IL-1β (tertiles), IL-10 (tertiles), heart disease, hypercholesterolemia, hydroxychloroquine, RF positivity, and anti-CCP positivity].

  • p < 0.05.

  • p < 0.01. QTc: corrected QT; anti-CCP: anticyclic citrullinated peptide antibodies; RF: rheumatoid factor; QTBAZ: QT corrected using the Bazett formula; CRP: C-reactive protein; IL: interleukin; QTFHS: QT corrected using the Framingham Heart Study formula; HCQ: hydroxychloroquine.